Non-Small Cell Lung Cancer Video Channel
Explore the latest insights and summaries from experts in Non-Small Cell Lung Cancer.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Insights from 2024 WCLC
WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion
FEATURING
Pyng Lee
- 1,388 views
- September 23, 2024
- 10
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 1,063 views
- December 17, 2024
- 5
Oncology 2024 Year in Review
Year in Review 2024 - NSCLC Perioperative Therapy
FEATURING
Balazs Halmos
- 647 views
- December 2, 2024
- 12
Memorial Sloan Kettering Cancer Center
Role of Surgery in Locally Advanced NSCLC
FEATURING
Katherine Gray
- 118 views
- January 17, 2025
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 630 views
- September 26, 2024
- 8
University of Colorado Cancer Center
Metastatic EGFRm NSCLC: 1L Therapy Options
FEATURING
Tejas Patil
- 470 views
- October 11, 2024
- 7
David Carbone
Multidisciplinary Panel Discussion: New Treatment Options for Surgically Resectable NSCLC
FEATURING
Brendon Stiles
- 335 views
- October 21, 2024
- 5
Fox Chase Cancer Center
Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options
FEATURING
Charu Aggarwal
- 145 views
- January 2, 2025
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Therapy Debate in NSCLC
FEATURING
Jan Von Der Thusen
- 242 views
- October 21, 2024
- 6
Fox Chase Cancer Center
IO Advances in Metastatic NSCLC Treatment
FEATURING
Hossein Borghaei
- 151 views
- January 2, 2025
- 3
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
FEATURING
Jason Porter
- 1,327 views
- February 23, 2024
- 7
Insights from 2024 WCLC
WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How Should We Proceed
FEATURING
Satoshi Ikeda
- 363 views
- September 23, 2024
- 1
ecancer
ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr
- 296 views
- October 11, 2024
- 2
Total Health
Treatment Updates in Early Stage NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 194 views
- October 29, 2024
- 3
UNC Lineberger Comprehensive Cancer Center
Treatment Strategies for Metastatic HER2-Mutant NSCLC
FEATURING
Shetal Patel
- 45 views
- December 3, 2024
- 1
Fox Chase Cancer Center
EGFR Mutations in NSCLC: Latest Updates and Key Changes
FEATURING
Joseph Bodor
- 99 views
- December 16, 2024
- 2
Integrity CE
Management of mNSCLC Without Actionable Mutations
FEATURING
Megan Baumgart,
Stephen Liu
- 128 views
- September 3, 2024
- 1
Giannis Mountzios
New Frontiers in NSCLC Treatment: Expanding Options Beyond Chemo-Immunotherapy and Docetaxel
- 240 views
- August 20, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - Debate Overview
FEATURING
Jessica Donington
- 157 views
- September 23, 2024
- 2
GRACE
Advancing Treatment in EGFR-Mutated NSCLC: Results From FLAURA2 and MARIPOSA Trials
FEATURING
Aakash Desai,
Fawzi Abu Rous
- 68 views
- December 1, 2024
- 1
Integrity CE
How the Experts Treat: Early Stage NSCLC With Curative Intent
FEATURING
Stephen Liu
- 150 views
- August 8, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Addition of Cytotoxic Chemotherapy to Targeted Therapy in NSCLC
FEATURING
Bruna Pellini
- 150 views
- October 1, 2024
- 1
MI&T Congressi
Neoadjuvant Chemoimmunotherapy in Unresectable NSCLC
FEATURING
Isabelle Opitz
- 154 views
- August 20, 2024
- 2
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-671
FEATURING
Luis Raez
- 909 views
- February 23, 2024
- 5
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
FEATURING
Raymond Osarogiagbon
- 451 views
- February 23, 2024
- 4
Insights from 2024 WCLC
WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations
FEATURING
Melina Marmarelis
- 111 views
- September 23, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Brain Metastases in Oncogene-Driven NSCLC - Timing, Sequency, and Modality of RT
FEATURING
Joe Chang
- 125 views
- September 18, 2024
MI&T Congressi
Neoadjuvant and Adjuvant Therapies in NSCLC: Are We Saving Lives?
FEATURING
Giorgio Scagliotti
- 186 views
- July 22, 2024
- 4
MI&T Congressi
How the Experts Treat: Neoadjuvant or Adjuvant Targeted Therapy in Resectable Oncogene-Addicted NSCLC
FEATURING
Jarushka Naidoo
- 161 views
- July 12, 2024
- 2
Shirish Gadgeel
Advancing Treatment Strategies for ALK-Positive Advanced NSCLC
- 38 views
- November 27, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Metastatic ALK+ NSCLC
FEATURING
Vincent Lam
- 78 views
- September 11, 2024
University of Illinois Cancer Center
Precision Oncology: Leveraging Biomarkers for 1L Treatment in mNSCLC
FEATURING
Ryan Nguyen
- 51 views
- December 5, 2024
- 1
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "The Latest Data in Oncogene-Addicted NSCLC"
FEATURING
Nicolas Girard
- 195 views
- July 11, 2024
- 1
Yale Cancer Center
Key NSCLC Trial Updates Including ADAURA and KEYNOTE-671
FEATURING
Sarah Goldberg
- 56 views
- October 21, 2024
- 1
Springer Healthcare IME
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
- 87 views
- October 29, 2024
- 1
MI&T Congressi
Optimal Duration of Immunotherapy in NSCLC
FEATURING
Giulia Pasello
- 96 views
- August 20, 2024
- 1
Brendon Stiles
Surgical Dogma, Reality, and Aspirations After Neoadjuvant Therapy for NSCLC
- 220 views
- April 29, 2024
- 2
North American Neuroendocrine Tumor Society
Demystifying Thoracic Neuroendocrine Neoplasms: Key Management Differences in TC, AC, LCNEC, and SCLC
FEATURING
Robert Ramirez
- 78 views
- September 10, 2024
- 1
Nebraska Oncology Society
Year in Review 2024 - Perioperative Immunotherapy in Resectable NSCLC
FEATURING
Joseph Murray
- 33 views
- January 5, 2025
Yale Cancer Center
Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanced NSCLC
FEATURING
Amin Nassar
- 489 views
- February 7, 2024
- 2
Yale Cancer Center
Key Advances in Lung Cancer Therapies: A Comprehensive Overview
FEATURING
Anne Chiang
- 33 views
- January 14, 2025
Insights from 2024 WCLC
WCLC 2024 Summary: Survival Outcomes and Pathologic Response After Chemoimmunotherapy in Resectable NSCLC
FEATURING
Daniele Marinelli
- 52 views
- September 18, 2024
- 2
Insights from 2023 ESMO Annual Meeting
Perioperative Immunotherapy Strategies in Resectable NSCLC After ESMO 2023
FEATURING
Giannis Mountzios
- 739 views
- October 30, 2023
- 14
Scripps Health
2024 Neuro-Oncology Update: NSCLC and Brain Mets
FEATURING
Tresa McGranahan
- 360 views
- April 2, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Local Consolidative Therapy for Oligometastatic NSCLC
FEATURING
Vincent Lam
- 67 views
- September 11, 2024
ecancer
ELCC 2024 Roundtable: "Latest Updates in EGFR Mutant NSCLC With a Focus on Exon 20 Mutation"
- 208 views
- May 1, 2024
- 2
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
FEATURING
Charu Aggarwal
- 387 views
- February 15, 2024
- 2
MI&T Congressi
How the Experts Treat: Adjuvant Immunotherapy for Resected NSCLC
FEATURING
Dolores Isla
- 91 views
- July 18, 2024
- 2
Luis Raez
Oligometastatic Lung Cancer & Stereotactic Radiation Therapy Utilization
- 168 views
- May 27, 2024
Yale Cancer Center
Progress in the Treatment of NSCLC
FEATURING
Roy Herbst
- 509 views
- December 20, 2023
- 3
MI&T Congressi
How the Experts Treat: Neoadjuvant Immunotherapy for Resected NSCLC
FEATURING
Mariano Provencio Pulla
- 87 views
- July 24, 2024
- 1
GRACE
Perioperative Therapies for Resectable NSCLC
FEATURING
Millie Das
- 328 views
- February 15, 2024
- 2
Rush University Medical Center
Current Unmet Needs and Challenges in 1L Treatment Approaches for EGFRm NSCLC
FEATURING
Mary Fidler
- 305 views
- February 28, 2024
- 2
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 102 views
- July 2, 2024
- 1
OncoAlert
Thoracic Surgery Updates From Recent NSCLC Trials
FEATURING
Brendon Stiles
- 294 views
- February 15, 2024
- 1
Yale Cancer Center
Year in Review: Progress in NSCLC Treatment
FEATURING
Roy Herbst
- 661 views
- October 22, 2023
- 7
Yale Cancer Center
Lung Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Therapy
FEATURING
Charles Balch
- 174 views
- April 3, 2024
- 1
OncoAlert
Early NSCLC Updates: EGFRm, ALK+ Disease & Neoadjuvant IO
FEATURING
Gilberto Lopes
- 242 views
- February 15, 2024
- 3
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
FEATURING
Bishal Gyawali
- 404 views
- November 15, 2023
- 7
Insights from ELCC 2024
ELCC 2024 Summary: "Combining New Drugs and RT in Lung Cancer"
FEATURING
Deborah Zhou
- 166 views
- April 10, 2024
2023 Evolution Conference
IO and Targeted Treatment for mNSCLC
FEATURING
Meghan Mooradian
- 466 views
- November 8, 2023
- 2
Insights from ELCC 2024
ELCC 2024 Insights: "Treatment Landscape for Stages I-III NSCLC in the US Community Setting Before and After 2020"
FEATURING
Jessica Donington
- 140 views
- April 11, 2024
- 2
COR2ED The Heart of Medical Education
ESMO 2024 Summary: BRAF-Altered Lung Cancer
FEATURING
Federico Cappuzzo,
David Planchard
- 32 views
- October 25, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Locally Advanced EGFR-Mutated NSCLC
FEATURING
Vincent Lam
- 40 views
- August 13, 2024
Total Health
West Cancer Center Updates on NSCLC
FEATURING
Jason Porter
- 195 views
- December 15, 2023
- 1
ecancer
ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates
FEATURING
Bishal Gyawali
- 46 views
- October 21, 2024
2023 Evolution Conference
Treatment Strategies for Early Stage NSCLC
FEATURING
Nagashree Seetharamu
- 314 views
- November 8, 2023
- 2
North American Neuroendocrine Tumor Society
Medical Therapy Options for Lung NETs
FEATURING
Robert Ramirez
- 30 views
- September 10, 2024
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 38 views
- July 2, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Recent Developments in the Treatment of Patients With EGFR ex 20 Ins NSCLC"
FEATURING
Paul Mitchell
- 307 views
- November 10, 2023
- 1
ecancer
ESMO 2023 Insights: "The Latest in NSCLC With Common EGFR Mutations"
- 315 views
- October 25, 2023
- 2
Memorial Sloan Kettering Cancer Center
Radiation for Unresectable NSCLC: Where Are We Now and Where Are We Going
FEATURING
Daniel Gomez
- 149 views
- December 13, 2023
- 3
ImmunoTherapy Bridge 2023
What’s New in NSCLC & Mesothelioma Immunotherapy
FEATURING
Alessandro Morabito
- 116 views
- January 19, 2024
- 2
MI&T Congressi
Radiotherapy for N2 Resected NSCLC
FEATURING
Cécile Le Péchoux
- 31 views
- July 12, 2024
- 1
OncoAlert
Year in Review: Lung Cancer Radiation Therapy
FEATURING
Charles Simone
- 113 views
- February 15, 2024
- 1
OncoAlert
Year in Review: Colorectal and Anal Cancers
FEATURING
Cathy Eng
- 58 views
- February 22, 2024
Fox Chase Cancer Center
Role of Radiation in the Management of Oligoprogressive NSCLC
FEATURING
Randi Cohen
- 9 views
- January 8, 2025
UNC Lineberger Comprehensive Cancer Center
Treatment Strategies for Metastatic KRAS-Mutant NSCLC
FEATURING
Shetal Patel
- 5 views
- December 3, 2024
ImmunoTherapy Bridge 2023
IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options to Cover the Unmet Need
FEATURING
Alessandro Morabito
- 96 views
- January 9, 2024
GRACE
Leveraging AI and Precision Oncology to Optimize Synergy Between Local and Systemic Therapies in the Management of Metastatic NSCLC
FEATURING
Puneeth Iyengar
- 62 views
- February 15, 2024
- 1
ImmunoTherapy Bridge 2023
Updates on Radiation and Immunotherapy
FEATURING
Silvia Formenti
- 71 views
- January 9, 2024
- 1
OncoAlert
Immunotherapy Highlights for Solid Tumors in 2023
FEATURING
John Haanen
- 56 views
- February 16, 2024
GRACE
Local Therapy for Patients With Oligoprogressive NSCLC
FEATURING
Puneeth Iyengar
- 48 views
- February 13, 2024
GRACE
Local Therapy for Oligometastatic NSCLC Patients After Frontline Therapy
FEATURING
Puneeth Iyengar
- 41 views
- February 13, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Contemporary LMD Clinical Trials: Design and Landscape
FEATURING
Priya Kumthekar
- 15 views
- April 30, 2024
GRACE
Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC
FEATURING
Puneeth Iyengar
- 9 views
- May 15, 2024
Therapeutic Agents
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-Deruxtecan Related ILD - A Real-World Experience
FEATURING
Kelsey Natsuhara
- 1,282 views
- October 14, 2024
- 6
Fox Chase Cancer Center
Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomic Alterations
FEATURING
Joshua Reuss
- 188 views
- January 8, 2025
- 3
Mariam Alexander
Lazertinib in 1L EGFR-Mutant NSCLC: Unique Mechanism and Benefits of Amivantamab Combination
- 338 views
- November 8, 2024
- 2
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,147 views
- April 16, 2024
- 12
Oncology 2024 Year in Review
Year in Review 2024 - Top Clinical Trials in Neuro-Oncology
FEATURING
Stephen Bagley
- 234 views
- December 20, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: MARIPOSA - Amivantamab + Lazertinib vs. Osimertinib in 1L EGFR-Mut Advanced NSCLC
FEATURING
Shirish Gadgeel
- 322 views
- September 20, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Developmental Therapeutics Highlights
FEATURING
Guru Sonpavde
- 298 views
- October 25, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
FEATURING
Luis Raez
- 712 views
- June 14, 2024
- 5
Total Health
Treatment Updates in Advanced and Metastatic NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 184 views
- October 29, 2024
- 1
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
FEATURING
Young Chae
- 1,224 views
- April 19, 2024
- 5
MI&T Congressi
Options for Osimertinib-Resistant NSCLC
FEATURING
Trever Bivona
- 205 views
- September 3, 2024
- 4
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: NSCLC
FEATURING
Rajat Thawani
- 281 views
- August 27, 2024
- 4
John Conibear
Managing EGFR-Mutant NSCLC Patients With Osimertinib Resistance
- 103 views
- November 21, 2024
- 2
Yale Cancer Center
Key Metastatic NSCLC Trial Updates Including MARIPOSA and FLAURA2
FEATURING
Sarah Goldberg
- 116 views
- October 21, 2024
- 1
West Virginia State Rheumatology Society
Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers
FEATURING
Jean Bustamante
- 433 views
- June 26, 2024
- 2
Luis Raez
Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage Disease
- 505 views
- May 27, 2024
- 5
UNC Lineberger Comprehensive Cancer Center
Targeted Therapies in Resected and Unresectable NSCLC
FEATURING
Shetal Patel
- 59 views
- December 3, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: FLAURA2 Trial - Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemo in EGFR-Mutated Advanced NSCLC
FEATURING
Natalia Valdivieso
- 159 views
- September 23, 2024
- 1
MI&T Congressi
ADC in Combination With Immunotherapy for NSCLC
FEATURING
Stephen Liu
- 221 views
- July 26, 2024
- 1
Integrity CE
Management of Stage IV NSCLC With Actionable Mutations
FEATURING
Grace Dy
- 182 views
- September 3, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 549 views
- July 5, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents in Lung Cancer
FEATURING
Pilar Garrido
- 161 views
- September 26, 2024
- 1
ecancer
Cemiplimab Monotherapy as 1L Treatment for Advanced NSCLC: EMPOWER-Lung 1 Study Results
FEATURING
Ana Baramidze
- 110 views
- November 4, 2024
- 1
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertinib + Chemo vs. Osimertinib Alone for Advanced EGFRm Disease
FEATURING
Pasi Janne
- 698 views
- February 23, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Insights: Biology of CNS Metastases in NSCLC
FEATURING
Timothy Burns
- 151 views
- September 19, 2024
- 3
Federico Cappuzzo
Current & Future Directions of IO in Early Stage NSCLC
- 119 views
- October 17, 2024
- 1
Dionysis Papadatos-Pastos
Optimizing Treatment Intensification in 1L EGFR-Mutated NSCLC
- 137 views
- September 26, 2024
Lung Cancer Europe (LuCE)
Targeted Therapy and Oncogene Addiction in Lung Cancer: New Developments
FEATURING
Benjamin Besse
- 78 views
- November 11, 2024
- 1
MI&T Congressi
New Immune Checkpoint Inhibitors in Lung Cancer
FEATURING
Solange Peters
- 203 views
- July 25, 2024
- 1
Fox Chase Cancer Center
Progress in Targeting ALK and ROS1 in NSCLC
FEATURING
Melina Marmarelis
- 62 views
- December 16, 2024
ecancer
ESMO and WCLC Updates on Common EGFR Mutations in NSCLC: Panel Discussion
- 54 views
- January 16, 2025
- 1
Iris Uras
Recent Advancements in KRASG12C Inhibitors for NSCLC Treatment
- 139 views
- October 2, 2024
- 1
MI&T Congressi
Current ADC Development in NSCLC
FEATURING
Hossein Borghaei
- 188 views
- July 18, 2024
- 2
MI&T Congressi
MET Exon 14 Skipping Mutations in NSCLC
FEATURING
Oliver Gautschi
- 194 views
- July 19, 2024
- 1
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Metastatic Setting
FEATURING
Michael Hwang
- 1,050 views
- December 13, 2023
- 13
Insights from 2024 WCLC
WCLC 2024 Insights: Highlights of Coming Advances in mNSCLC - Cytotoxics, IO, and KRAS Inhibitors
FEATURING
Brian Henick
- 117 views
- September 19, 2024
GRACE
Targeted Therapy in Lung Cancer: Side Effects
FEATURING
Tejas Patil
- 103 views
- September 12, 2024
MI&T Congressi
How the Experts Treat: Adjuvant or Neoadjuvant Immunotherapy for NSCLC
FEATURING
Tina Cascone
- 144 views
- July 24, 2024
- 2
MI&T Congressi
How the Experts Manage: ADC-Associated Toxicities in NSCLC
FEATURING
Natasha Leighl
- 180 views
- August 8, 2024
Fred Hutchinson Cancer Center
Practical Guidelines on Testing & Treatment of BRAF V600+ NSCLC
FEATURING
Christina Baik
- 101 views
- August 28, 2024
- 1
Yale Cancer Center
Resectable NSCLC: Perioperative Immunotherapy and Multidisciplinary Care
FEATURING
Gavitt Woodard
- 39 views
- January 14, 2025
Lorenzo Belluomini
Clinical Insights on the Management of Edema Associated With MET Inhibitors in NSCLC
- 224 views
- June 17, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: LAURA Study - Osimertinib After Definitive CRT in Unresectable Stage III EGFRm NSCLC
FEATURING
Terufumi Kato
- 96 views
- September 18, 2024
Nebraska Oncology Society
Year in Review 2024 - Targeted Therapy for NSCLC
FEATURING
Joseph Murray
- 36 views
- January 5, 2025
MI&T Congressi
New Drugs as Maintenance Therapy After CRT in Stage III NSCLC
FEATURING
Fabrice Barlesi
- 112 views
- August 20, 2024
- 1
Clarissa Mathias
TROP2, CEACAM5, and MET Antibody-Drug Conjugates in NSCLC
- 33 views
- December 2, 2024
- 1
Springer Healthcare IME
Targeted Therapy for NTRK Fusion-Positive Cancers
FEATURING
Alex Drilon
- 82 views
- October 1, 2024
- 1
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Changing Systemic Therapy Post Oligoprogression in the CNS
FEATURING
Gregory Riely
- 243 views
- April 30, 2024
- 2
MI&T Congressi
Pharmacology of ADC Classes in Lung Cancer
FEATURING
Marzia Del Re
- 92 views
- August 27, 2024
- 1
Dana-Farber Cancer Institute
Risk of Hepatotoxicity From Sequential IO Followed by KRASG12C Targeted Therapy in NSCLC
FEATURING
Biagio Ricciuti
- 228 views
- May 22, 2024
- 1
MI&T Congressi
How the Experts Manage: Cardiotoxicity and IO in NSCLC
FEATURING
Jordi Remon Masip
- 117 views
- August 2, 2024
MI&T Congressi
Options for BRAF-Mutated NSCLC Patients
FEATURING
David Planchard
- 136 views
- July 16, 2024
Insights from 2023 ESMO Annual Meeting
PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EGFR Exon 20 Insertion-Mutated Advanced NSCLC
FEATURING
Nicolas Girard
- 842 views
- November 17, 2023
- 7
Moffitt Cancer Center
Future Targets for Cell Therapy in Lung Cancer: Breaking the Glass Ceiling
FEATURING
Benjamin Creelan
- 23 views
- December 6, 2024
- 1
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Successes and Challenges of Early Drug Development for Brain Metastasis
FEATURING
Alex Drilon
- 308 views
- April 30, 2024
- 2
GRACE
Newer Types of Treatment for Lung Cancer: ADCs and Bispecifics
FEATURING
Lyudmila Bazhenova
- 333 views
- February 15, 2024
- 1
Integrity CE
TROP-2 ADCs for the Treatment of HR+/HER2- BC, TNBC, and NSCLC: Advancing Care in the Community Oncology Setting
FEATURING
Lee Schwartzberg,
Jason Porter
- 125 views
- March 20, 2024
- 1
MI&T Congressi
The Role of IO for Oncogene-Addicted NSCLC
FEATURING
Francesco Passiglia
- 58 views
- August 20, 2024
- 1
Insights from 2023 ESMO Asia Annual Meeting
Oncogene-Driven NSCLC: RET, NTRK, and ROS1
FEATURING
Junko Tanizaki
- 418 views
- February 7, 2024
Maen Hussein
Improving Outcomes in NSCLC: Treatment and Prognostication Updates
- 293 views
- February 23, 2024
- 7
UCLA Health
HERTHENA-Lung01 Study: Patritumab Deruxtecan as a HER3 Target in EGFRm Advanced NSCLC
FEATURING
Aaron Lisberg
- 150 views
- May 9, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Cemiplimab Monotherapy in PD-L1 ≥50% Advanced NSCLC - 5-Year EMPOWER-Lung 1 Results
FEATURING
Ana Baramidze
- 51 views
- September 19, 2024
MI&T Congressi
New Drugs for HER2 Deregulated NSCLC
FEATURING
Egbert Smit
- 54 views
- September 3, 2024
MI&T Congressi
Anti-ALK NSCLC Agents as Adjuvant Therapy
FEATURING
Marina Chiara Garassino
- 82 views
- August 8, 2024
GRACE
Advancing Treatment in EGFR-Mutated NSCLC: Results From MARIPOSA2 and LAURA Trials
FEATURING
Aakash Desai,
Fawzi Abu Rous
- 20 views
- December 1, 2024
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 68 views
- July 2, 2024
- 1
Insights from TTLC 2024 Annual Meeting
TTLC 2024 Insights: "NTRK and NRG Fusions in NSCLC"
FEATURING
Liza Villaruz
- 301 views
- March 5, 2024
Insights from ELCC 2024
ELCC 2024 Insights: "Vaccine-Based Therapy in Lung Cancer"
FEATURING
Marco Tagliamento
- 175 views
- April 10, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: The Global TRUST-II Study - Efficacy & Safety of Taletrectinib in Patients With ROS1+ NSCLC
FEATURING
Geoffrey Liu
- 37 views
- October 11, 2024
Lung Cancer Europe (LuCE)
Targeted Therapy and Oncogene Addiction in Lung Cancer: Drug Access
FEATURING
Benjamin Besse
- 24 views
- November 11, 2024
- 1
Blanca Ledezma
Practical Guidance for the Management of Adverse Events in Patients With NSCLC Receiving KRASG12C Inhibitors
- 633 views
- November 14, 2023
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Evolution Trial - RT-Free Pembro + Chemo in High PD-L1 LA-NSCLC"
FEATURING
Akito Hata
- 129 views
- June 10, 2024
- 2
MI&T Congressi
IO Long-Term Survival in Advanced NSCLC
FEATURING
Rolf A. Stahel
- 56 views
- July 25, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage III NSCLC
FEATURING
William William
- 41 views
- September 23, 2024
Santiago Viteri
The VISION Trial: Tepotinib in Patients With NSCLC Harboring METex14 Skipping Mutation
- 137 views
- May 10, 2024
- 1
Yale Cancer Center
Treatment Approach to ROS1 Rearranged NSCLC
FEATURING
Michael Grant
- 518 views
- October 19, 2023
- 2
Total Health
Selected Targeted Therapies in NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 29 views
- October 29, 2024
ecancer
ESMO 2024 Review: Amivantamab ± Chemo in EGFRm aNSCLC Post-Osimertinib - MARIPOSA-2 Interim OS
FEATURING
Enriqueta Felip
- 20 views
- January 21, 2025
Robert Hsu
Unmet Need in NSCLC Treatment Options Following Progression on 1L IO + Chemo
- 436 views
- November 15, 2023
- 4
Yale Cancer Center
Targeting Drug-Tolerant Persister Cells: Osimertinib Combinations in NSCLC
FEATURING
Pasi Janne
- 196 views
- February 23, 2024
- 1
MI&T Congressi
Selecting Patients for CTLA4 Therapy for NSCLC
FEATURING
Rafal Dziadziuszko
- 43 views
- July 25, 2024
Yale Cancer Center
GI Oncology Year in Review: Key mCRC Studies Including CheckMate 8HW & CodeBreaK 300
FEATURING
Michael Cecchini
- 113 views
- March 11, 2024
- 1
Dana-Farber Cancer Institute
Updates in KRAS G12C Mutant NSCLC: Demographics, Clinical Features, Genomics, and Treatment
FEATURING
Biagio Ricciuti
- 240 views
- January 8, 2024
- 1
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Docetaxel in Previously Treated Advanced/Metastatic NSCLC"
FEATURING
Aaron Lisberg
- 325 views
- November 17, 2023
- 3
COR2ED The Heart of Medical Education
Oncogene-Addicted NSCLC Highlights From WCLC & ESMO 2024
FEATURING
Herbert Loong
- 35 views
- October 28, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CCTG BR.31 - Adjuvant Durvalumab in Completely Resected NSCLC
FEATURING
Glenwood Goss
- 19 views
- October 21, 2024
MI&T Congressi
Maintenance IO in Stage III Unresectable NSCLC
FEATURING
Anne-Marie Dingemans
- 37 views
- July 22, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Health-Related QoL Outcomes With Adagrasib vs. Docetaxel in KRASG12C-Mutated aNSCLC - KRYSTAL-12
FEATURING
Robert Jotte
- 19 views
- October 28, 2024
Insights from ELCC 2024
Advancing Lung Adenocarcinoma Treatment: Establishing KRAS-Driven Organoids for Drug Screening
FEATURING
Isa Tas
- 120 views
- April 18, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Long-Term Follow Up on Pembro + Itacitinib in PD-L1 Positive Metastatic NSCLC
FEATURING
Melina Marmarelis
- 22 views
- September 23, 2024
ecancer
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 31 views
- July 2, 2024
- 1
Insights from 2023 WCLC
WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSCLC With PD-L1 Tumor Proportion Score <1%"
FEATURING
Shirish Gadgeel
- 305 views
- October 9, 2023
- 1
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: New Drug Targets in EGFRm Disease - TROP2
FEATURING
Pasi Janne
- 119 views
- February 23, 2024
- 2
University of Colorado Cancer Center
EGFR Exon 20 Insertion Mutations in NSCLC: Optimal and “Soon to Be Optimal” Therapy
FEATURING
Tejas Patil
- 206 views
- December 4, 2023
- 3
MI&T Congressi
Adaptive Mechanisms of Resistance to G12C(OFF) Inhibitors in NSCLC
FEATURING
Chiara Ambrogio
- 27 views
- September 3, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab in TKI-Naïve EGFRm mNSCLC"
FEATURING
Xiuning Le
- 229 views
- November 8, 2023
- 2
ecancer
ESMO 2023 Insights: "Phase 3 CheckMate-77T Study - Perioperative Nivo + Chemo for Resectable NSCLC"
FEATURING
Tina Cascone
- 306 views
- October 25, 2023
- 6
ecancer
ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib & Panitumumab in KRAS G12Cm mCRC"
FEATURING
Filippo Pietrantonio
- 266 views
- October 27, 2023
- 1
GRACE
Neoadjuvant Treatment for Patients With NSCLC
FEATURING
Joshua Reuss
- 113 views
- February 13, 2024
Northwestern Medicine Oncology and Hematology
Can Double-Lung Transplant Be a Treatment Option for Stage 4A Lung Cancers?
FEATURING
Young Chae
- 33 views
- September 3, 2024
- 1
GRACE
Key Points From the ADAURA Trial: Osimertinib in NSCLC
FEATURING
Joshua Reuss
- 107 views
- February 13, 2024
Integrity CE
The Evolving Treatment Journey for Patients With Unresectable Stage III NSCLC in the Era of Immune Therapy
FEATURING
Ticiana Leal
- 91 views
- January 26, 2024
MI&T Congressi
Anti-EGFR Agents in the Adjuvant NSCLC Setting
FEATURING
Yi-Long Wu
- 27 views
- August 2, 2024
Insights from ELCC 2024
ELCC 2024 Insights: "ETOP ABC-Lung Trial - Atezo + Bev & Chemo in EGFRm NSCLC With Acquired Resistance"
FEATURING
Martin Früh
- 60 views
- April 11, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: KRAS G12C Inhibitor IBI351 in Advanced NSCLC
FEATURING
Qing Zhou
- 23 views
- October 17, 2024
Louisville Hematology Highlights
Using Tumor Infiltrating Lymphocytes to Induce Solid Tumor Regression
FEATURING
Jason Chesney
- 82 views
- February 26, 2024
GRACE
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutations
FEATURING
Lyudmila Bazhenova
- 39 views
- May 1, 2024
GRACE
Adding to Targeted Therapy in NSCLC: Current Statistics and Biology
FEATURING
Puneeth Iyengar
- 87 views
- February 13, 2024
GRACE
Antibody Drug Conjugates and How They Are Used in NSCLC
FEATURING
Lyudmila Bazhenova
- 33 views
- May 1, 2024
ImmunoTherapy Bridge 2023
Best of SITC 2023 for Clinical Development and IO Trials
FEATURING
Paolo A. Ascierto
- 94 views
- January 11, 2024
- 1
OncoAlert
Updates in Targeted Therapies for Solid Tumors
FEATURING
Benedikt Westphalen
- 66 views
- February 17, 2024
ecancer
ESMO 2023 Insights: "Phase 2 KRYSTAL-7 Trial - Adagrasib+Pembro Combo for KRASG12C+, Treatment-Naïve, Advanced NSCLC"
FEATURING
Pasi Janne
- 98 views
- October 25, 2023
Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"
FEATURING
Masahiro Tsuboi
- 53 views
- January 3, 2024
- 1
Lorenzo Belluomini
Selpercatinib in Patients With RET Fusion-Positive NSCLC: Where Are We Now?
- 60 views
- December 22, 2023
- 1
Insights from 2023 WCLC
WCLC 2023 Insights: "Mechanisms of Resistance to KRAS G12C Inhibitors in NSCLC"
FEATURING
Biagio Ricciuti
- 98 views
- October 9, 2023
- 1
Icahn School of Medicine at Mount Sinai
PanRAF Inhibitors in NSCLC
FEATURING
Rajwanth Veluswamy
- 24 views
- May 7, 2024
Fox Chase Cancer Center
Special Populations in Lung Cancer: KRAS, STK11, and KEAP1 Mutations and IO
FEATURING
Suki Padda
- 3 views
- December 16, 2024
Insights from 2023 WCLC
WCLC 2023 Insights: "PD-L1 Subgroups in the Phase 3 LUNAR Study - TTFields and Immune Checkpoint Inhibitor in mNSCLC"
FEATURING
Rupesh Kotecha
- 72 views
- October 17, 2023
- 1
Oncology Data Advisor
Additional Advances in Immune-Related Adverse Events in Lung Cancer: Research and Clinical Trials
FEATURING
Beth Sandy
- 13 views
- September 18, 2024
Yale Cancer Center
Breakthrough Radiotherapy as a New Option for Bone and Lung Cancer Patients
FEATURING
Kimberly Johung
- 16 views
- April 30, 2024
ecancer
ESMO 2024 Review: Safety and Antitumor Activity of Zipalertinib in EGFR Exon 20 NSCLC After Amivantamab
FEATURING
Pascale Tomasini
- 5 views
- January 21, 2025
Insights from ELCC 2024
ELCC 2024 Insights: "CIS-DPI-01 Study - Dry Powder Inhaled Cisplatin in Stage IV NSCLC"
FEATURING
Mariana Brandão
- 12 views
- April 11, 2024
ecancer
PROFIT Study: Use of NK-1 Inhibitor HR20013 in Preventing Chemo-Induced Nausea in Advanced NSCLC
FEATURING
Li Zhang
- 6 views
- November 4, 2024
Masonic Cancer Center, University of Minnesota
Molecular Pathways and Therapeutic Implications in Pulmonary Metastasis
FEATURING
Mark Headley
- 4 views
- December 3, 2024
ecancer
ESMO 2024 Review: Osimertinib After CRT in Unresectable Stage 3 EGFRm NSCLC - CNS and Distant Progression Results From LAURA
FEATURING
Enriqueta Felip
- 9 views
- January 21, 2025
Diagnostics & Biomarkers
Fox Chase Cancer Center
Nodules and Lung Cancer Screening
FEATURING
Rohit Kumar
- 379 views
- January 5, 2025
- 4
Fox Chase Cancer Center
Thoracic Malignancies From an Interventional Pulmonologist's Perspective
FEATURING
Christopher Manley
- 215 views
- January 9, 2025
- 4
ecancer
Surveillance Imaging in Solid Tumors: More Complicated Than It Appears
FEATURING
Christopher Booth
- 280 views
- October 25, 2024
- 4
Yale Cancer Center
Lung Cancer Screening Guidelines and Care
FEATURING
Eric Winer,
Lynn T Tanoue
- 252 views
- December 6, 2024
- 2
MI&T Congressi
Mediastinal Staging of Lung Cancer
FEATURING
Rocco Trisolini
- 499 views
- July 22, 2024
- 5
Insights from 2024 WCLC
WCLC 2024 Insights: Augmented Imaging Techniques for Peripheral Nodules
FEATURING
Carrie Leong
- 283 views
- October 2, 2024
- 2
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 194 views
- October 29, 2024
- 5
Arianna Marinello
Clinical Application of ctDNA Monitoring in Resected Early NSCLC
- 221 views
- October 1, 2024
- 6
UChicago Medicine
Biomarker Testing in aNSCLC: Current Guidelines, Gaps, and Impact on Treatment Outcomes
FEATURING
Rajat Thawani
- 123 views
- December 6, 2024
- 5
Oncology Data Advisor
World Lung Cancer Day: Key Insights and Advances in Lung Cancer Treatment and Research
- 153 views
- September 11, 2024
- 1
Springer Healthcare IME
The Era of Precision Oncology
FEATURING
Jaime Schneider
- 141 views
- October 29, 2024
- 1
Springer Healthcare IME
Landscape of Biomarker Testing for NSCLC
FEATURING
Fernando López-Ríos
- 153 views
- October 1, 2024
- 1
GRACE
Targeted Therapy in Lung Cancer: The Importance of Biomarkers
FEATURING
Tejas Patil
- 113 views
- September 12, 2024
- 1
MI&T Congressi
How to Select EGFR-Mutated Patients for EGFR+CT Combo in NSCLC
FEATURING
Pasi Janne
- 153 views
- July 26, 2024
- 2
GRACE
An Overview of KRAS+ NSCLC and Diagnostic Testing
FEATURING
Jia Luo
- 117 views
- September 12, 2024
- 1
ecancer
Predicting Clinical Outcomes in mNSCLC With TROP2 Expression: Insights From TROPION-Lung01
FEATURING
Marina Garassino
- 90 views
- November 4, 2024
Yale Cancer Center
Precision Medicine Strategies for Monitoring Treatment Response and Testing MRD in NSCLC
FEATURING
Amin Nassar
- 115 views
- August 28, 2024
- 3
Houston Methodist
Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Cell Lung Cancer
FEATURING
Sinchita Roy-Chowdhuri
- 296 views
- April 3, 2024
- 6
Moffitt Cancer Center
Finding Lung Cancer Early Saves Lives: The Moffitt Lung Cancer Early Detection Program
FEATURING
Lary A Robinson
- 45 views
- November 5, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Summary: Minimally Invasive Monitoring of Immunotherapy Response via ctDNA Approaches in NSCLC
FEATURING
Valsamo Anagnostou
- 68 views
- September 20, 2024
- 1
Society for Advanced Bronchoscopy
Lung Cancer: New Frontiers in Diagnosis & Treatment to Challenge the Old Paradigm
FEATURING
Abbie Begnaud
- 27 views
- December 18, 2024
- 1
Cleveland Clinic Hospital Based Care Institute
Molecular Testing on EBUS-TBNA Specimen
FEATURING
Atul C. Mehta
- 83 views
- August 19, 2024
- 2
Yale Cancer Center
EGFR Mutations in Lung Cancer and the Future of Precision Medicine in Cancer Treatment
FEATURING
Katerina Politi
- 74 views
- October 7, 2024
- 1
Insights from ELCC 2024
ELCC 2024 Insights: "Small Numbers, Big Impact - The Importance of Testing for Rare Mutations in mNSCLC"
FEATURING
Luka Brcic
- 287 views
- April 11, 2024
- 2
ecancer
WCLC 2024 Review: PAPILLON - TP53 Co-Mutations and ctDNA Clearance in EGFR Ex20ins-Mutated NSCLC
FEATURING
Pascale Tomasini
- 18 views
- January 21, 2025
Lung Cancer Europe (LuCE)
Targeted Therapy and Oncogene Addiction in Lung Cancer: Understanding EGFR and ALK Pathways
FEATURING
Benjamin Besse
- 30 views
- November 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Emerging Molecular Targets in Thymic Epithelial Tumors
FEATURING
Anja Roden
- 47 views
- September 26, 2024
Lung Cancer Europe (LuCE)
Immunotherapy and PD-L1 in Non-Oncogene Addicted Lung Cancer
FEATURING
Benjamin Besse
- 20 views
- November 11, 2024
Springer Healthcare IME
The Detection of NTRK Gene Fusions in NSCLC
FEATURING
Caterina Marchiò
- 45 views
- October 1, 2024
MI&T Congressi
Perspectives for NSCLC Patients Not Obtaining Complete Pathological Response
FEATURING
Tony Mok
- 62 views
- July 18, 2024
ecancer
ESMO 2024 Insights: PIONeeR Trial - IO Resistance Pathways Investigated to Tailor Combination Advanced NSCLC Therapy
FEATURING
Pascale Tomasini
- 28 views
- October 11, 2024
Insights from ELCC 2024
ELCC 2024 Insights: "AI for Diagnosis and Predictive Biomarkers in Thoracic Oncology"
FEATURING
Paul Hofman
- 101 views
- May 9, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving 1L Osimertinib for EGFRm mNSCLC
FEATURING
Fangdi Sun
- 29 views
- September 18, 2024
- 1
University of Illinois Cancer Center
KRASG12C Testing in NSCLC
FEATURING
Frank Weinberg
- 278 views
- December 20, 2023
Insights from 2024 WCLC
WCLC 2024 Insights: Risk-Adapted and Response-Adapted Strategies for Stage 3 NSCLC
FEATURING
Andrea Filippi
- 28 views
- October 11, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
State-of-the-Art Imaging for Brain Metastasis
FEATURING
Benjamin Ellingson
- 127 views
- April 30, 2024
- 1
ecancer
ESMO 2024 Review: Mechanisms of Acquired Resistance to 1L Amivantamab + Lazertinib vs. Osimertinib in EGFRm aNSCLC
FEATURING
Enriqueta Felip
- 10 views
- January 21, 2025
MI&T Congressi
MRD in Early Stage Oncogene-Addicted NSCLC
FEATURING
Nicola Normanno
- 48 views
- August 2, 2024
Kishu Ranjan
Biomarker Potential of HLA Class I APM Protein Downregulation in NSCLC
- 19 views
- November 25, 2024
- 1
ecancer
Best of ASCO® 2024: Biomarkers, Predictive, and Prognostic Factors of Resistance to IO in NSCLC
FEATURING
Ignacio Gil-Bazo
- 37 views
- August 2, 2024
ecancer
Best of ASCO® 2024: Uncommon Genetic Aberrations in Advanced NSCLC - NTRK, RET, NRG
FEATURING
Luis Raez
- 37 views
- August 8, 2024
- 1
Lung Cancer Europe (LuCE)
Using Real-World Data in Lung Cancer Research to Improve Cancer Care and Outcomes
FEATURING
Eleni Kokkotou
- 19 views
- November 7, 2024
Memorial Sloan Kettering Cancer Center
Advances in Resectable NSCLC
FEATURING
Katherine Gray
- 151 views
- December 13, 2023
- 1
Aadel Chaudhuri
ASTRO 2023 Insights: "ctDNA for Early Risk Stratification of Oligometastatic Lung Cancer"
- 213 views
- November 3, 2023
- 3
MI&T Congressi
Potential Role of ADC in Early Stage NSCLC
FEATURING
Enriqueta Felip
- 35 views
- September 3, 2024
Insights from ELCC 2024
ELCC 2024 Insights: "Can We Modulate Lung Cancer IO Response With Microbiome?"
FEATURING
Paul Baas
- 47 views
- May 1, 2024
GRACE
The Importance of Biomarker Testing in NSCLC: What Is Liquid Biopsy?
FEATURING
Aakash Desai
- 85 views
- February 13, 2024
Insights from 2023 WCLC
Molecular and Clinical Characterization of NSCLC With MET Fusions
FEATURING
Chul Kim
- 164 views
- October 22, 2023
- 1
Insights from 2023 WCLC
WCLC 2023 Insights: "NSCLC Microenvironment Subtypes Correlate with Response and Survival to Immune Checkpoint Inhibitor Therapy"
FEATURING
Dhruv Bansal
- 102 views
- October 22, 2023
- 1
ecancer
ESMO and WCLC Updates on EGFR Exon 20 Insertion in NSCLC: Panel Discussion
- 8 views
- January 21, 2025
Insights from ELCC 2024
The ITMIG/IASLC Thymic Nodal Map: A Re-Assessment After the 9th TNM for an Optimal Pre-Treatment Stage
FEATURING
Edith Marom
- 12 views
- April 10, 2024
Disease Overview
Lung Cancer Europe (LuCE)
Overview of Lung Cancer Classification and Rare Alterations
FEATURING
Benjamin Besse
- 197 views
- November 11, 2024
University of Colorado Cancer Center
History of Cancer and Its Treatment: What Will It Take to Cure?
FEATURING
Christopher Lieu
- 335 views
- August 2, 2024
- 4
GRACE
Lung Resection in Early Stage NSCLC: An Overview
FEATURING
Chi-Fun Jeffrey Yang
- 263 views
- May 15, 2024
- 1
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
The Changing Prognosis of Lung Cancer Brain Metastases
FEATURING
Sarah Goldberg
- 345 views
- April 30, 2024
- 4
MI&T Congressi
N2 Disease in NSCLC: Who Is Resectable?
FEATURING
Mariana Brandão
- 128 views
- July 24, 2024
- 3
Fox Chase Cancer Center
Candidates for Surgical Resection in Lung Cancer: Criteria and Considerations
FEATURING
Stacey Su
- 27 views
- January 8, 2025
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: The Impact of Air Pollution on Lung Cancer in Developing Countries
FEATURING
Upal Basu Roy
- 31 views
- September 23, 2024
- 1
OncoAlert
Treating Lung Cancer With Limited Resources
FEATURING
Yaala Saady Raof
- 179 views
- February 15, 2024
- 4
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Type I IFN Response in Brain Metastasis
FEATURING
Qingrong Chen
- 75 views
- April 30, 2024
- 1
GRACE
Surgery for Lung Cancer: Types and Considerations
FEATURING
Chi-Fun Jeffrey Yang
- 117 views
- February 15, 2024
- 1
Masonic Cancer Center, University of Minnesota
Immune Microenvironment in Pulmonary Metastasis
FEATURING
Mark Headley
- 15 views
- December 3, 2024
Yale Cancer Center
Yale Cancer Center Updates: Lung Cancer Awareness Month
FEATURING
Michael Cohenuram
- 106 views
- February 7, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Occupational Exposure and Lung Cancer
FEATURING
Paul Demers
- 19 views
- September 19, 2024
Yale Cancer Center
Investigating the Complex Biology of Drug Resistance for Clinical Impact in Lung Cancer
FEATURING
Katerina Politi
- 27 views
- May 2, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Analysis of Lung Cancer-Specific Patient-Reported Outcome Measures - Results From the PRO4All Project
FEATURING
Alberto Servetto
- 22 views
- September 23, 2024
Masonic Cancer Center, University of Minnesota
Dendritic Cells and Their Role in Pulmonary Metastasis
FEATURING
Mark Headley
- 8 views
- December 3, 2024
Insights from ELCC 2024
ELCC 2024 Insights: "Interim Analysis of the LUDICAS Study - Sexual Dysfunction in Patients With Lung Cancer"
FEATURING
Aylen Ospina
- 14 views
- April 10, 2024
Case Studies
GRACE
Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights From the LAURA Study
- 73 views
- November 5, 2024
UChicago Medicine 12th International Clinical Cancer Genomics Conference
Precision Medicine in NSCLC
FEATURING
Stacy Gray
- 283 views
- May 15, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Radiation Toxicities in The Era of Chemo-Immunotherapy
FEATURING
Percy Lee
- 99 views
- September 24, 2024
- 1
GRACE
Case-Based Panel: Managing EGFR Exon 21 L858R mNSCLC and Insights From the FLAURA 2 Study
- 44 views
- November 5, 2024
Fox Chase Cancer Center
Surgical Approaches After Neoadjuvant Treatment in Lung Cancer
FEATURING
Stacey Su
- 22 views
- January 8, 2025
- 1
Yale Cancer Center
76 y/o Female With Hypertension and History of Smoking: Lung Cancer Screening Case Discussion
- 200 views
- March 11, 2024
- 3
MI&T Congressi
Surgery at the Time of Immunotherapy for Early Stage NSCLC
FEATURING
Jonathan Spicer
- 62 views
- July 12, 2024
Cleveland Clinic Taussig Cancer Institute
Case Discussion: 63 y/o F With NSCLC and Tracheobronchitis as a Pulmonary irAE
FEATURING
Nathaniel Myall
- 36 views
- September 26, 2024
Total Health
65 y/o Male Presented With Cough and Left Upper Lobe Mass: NSCLC Case Expert Panel Discussion
- 129 views
- February 29, 2024
Yale Cancer Center
Case Review: Advanced NSCLC in a 47 y/o Male With Smoking History and Back Pain
- 15 views
- January 14, 2025
Integrity CE
Case Discussion: 59 y/o Former Smoker With Stage 3A NSCLC
FEATURING
Ticiana Leal
- 108 views
- January 26, 2024
- 1
Total Health
Case-Based Clinical Updates in NSCLC: 63 y/o With RET-Altered Disease
- 208 views
- October 17, 2023
- 1
ecancer
ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"
FEATURING
Joseph Greer
- 28 views
- June 20, 2024
- 1
Total Health
73 y/o Chinese Female With Large LUL Mass and Pleural Mets: NSCLC Molecular Tumor Board
FEATURING
Lee Schwartzberg
- 47 views
- February 28, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Mitigating Chemoradiation Toxicity in LA-NSCLC
FEATURING
Dawn Owen
- 17 views
- October 1, 2024
Total Health
Case-Based Clinical Updates in NSCLC: 75 y/o Female With a History of Smoking and COVID-19 Pneumonia
- 67 views
- October 17, 2023
- 2
Yale Cancer Center
Case Study of a 57 y/o Female Smoker With Melanoma History & Insights on Ground-Glass Nodules
FEATURING
Elizabeth Allard,
Gavitt Woodard
- 7 views
- January 15, 2025
Insights from ELCC 2024
ELCC 2024 Insights: "The Impact of Brain Metastases on Quality of Life"
FEATURING
Debra Montague
- 14 views
- April 18, 2024